To test the hypothesis that increases in lung superoxide dismutase can cause tolerance to pulmonary oxygen toxicity, we studied transgenic mice which constitutively express elevated levels of the human copper-zinc SOD (CuZnSOD). Upon exposure to hyperoxia (greater than 99% O2, 630 torr) the transgenic CuZnSOD mice showed increased survival, decreased morphologic evidence of lung damage such as edema and hyaline membrane formation, and reduction in the number of lung neutrophils. During continuous exposure to oxygen, both control and transgenic animals who successfully adapted to hyperoxia showed increased activity of lung antioxidant enzymes such as glutathione peroxidase (GPX), glutathione reductase (GR), and glucose-6-phosphate dehydrogenase (G6PD), whereas superoxide dismutase activity remained unchanged. The results show that expression of elevated levels of CuZnSOD decreases pulmonary oxygen toxicity and associated histologic damage and mortality.
Introduction
The potential clinical use of superoxide dismutase (SOD)' to decrease pulmonary oxygen toxicity has been investigated in several systems. In a study of humans exposed to increased inspired oxygen tensions for prolonged periods, administering bovine superoxide dismutase (SOD) subcutaneously in infants with respiratory distress syndrome palliated bronchopulmonary dysplasia (1) . However, a detailed morphologic study done in newborn rats developing bronchovascular dysplasia as a result of early exposure to oxygen did not demonstrate any 1 . Abbreviations used in this paper: G6PD, glucose-6-phosphate dehydrogenase; GPX, glutathione peroxidase, GR, glutathione reductase, SOD, superoxide dismutase. palliative effect of SOD injections despite large increases in extracellular SOD. No benefit, in terms of decreasing vascular remodeling or developmental failure due to short-term exposure to hyperoxia, was afforded by extracellular SOD (2) . In pulmonary epithelial and vascular endothelial cells, important targets of hyperoxic damage, SOD delivered in liposomes to increase intracellular SOD decreased the toxicity due to hyperoxic exposure (3, 4) . Liposome-encapsulated SOD has also been effective in decreasing pulmonary 02 toxicity in both adult and newborn rats when delivered intravenously, intratracheally, or intraperitoneally (5) (6) (7) . In these models, concomitantly administered, liposomal catalase has provided optimal tolerance.
In a variety of other models for tolerance to hyperoxic lung damage, increases in lung superoxide dismutase activities also have been identified, frequently with associated increases in enzymes of the glutathione redox cycle and/or catalase (8) (9) (10) (11) (12) (13) (14) . Both mitochondrial (MnSOD) and cytoplasmic (CuZnSOD) forms of SOD have been suggested to be important in multiple models of tolerance to pulmonary oxygen toxicity in adult rats and in newborns of several species. The potential relative importance of each SOD in affording lung protection is unclear. Although enzymes of the glutathione redox cycle also have been noted frequently to be elevated, these changes have been reported less consistently than those for the superoxide dismutases. It is difficult to separate the relative contribution of increases in detoxifiers ofperoxides from that of SOD in many of these models. Because additional stresses or lung biochemical changes are induced commonly in animals by the methods producing tolerance, novel approaches are needed to define more specifically the relative importance of each antioxidant enzyme in vivo.
Transgenic animals offer a new means for more selectively altering antioxidant enzymes. We examined the responses to hyperoxia of a previously characterized transgenic mouse with constitutive expression ofelevated levels ofhuman copper-zinc superoxide dismutase (CuZnSOD). We found that these mice had an increased development of tolerance to hyperoxia associated with decreased histopathologic evidence oflung damage including edema, hyaline membrane formation, and inflammation.
Methods
Transgenic mice. Transgenic mice harboring the human CuZnSOD gene were produced by microinjection of fertilized eggs with a linear 14.5-kb fragment of human genomic DNA containing the entire CuZnSOD gene, including its regulatory sequences, as previously described (15, 16) . TgHS-5 1 progeny, as used in these studies, contained five copies of the human CuZnSOD gene in their genomes. The mice used were derived from outbred matings between CBYB/6 [(BALB/ Transgenic mice with stable expression ofelevated levels ofhuman CuZnSOD were bred in a virus-free animal facility at Colorado State University. TgHS-51 homozygote, heterozygote, and control mice (15) , identified by Southern blot analysis (16) , SOD activity gel (16, 17) , and by pedigree analysis done by characterizing their offspring with the latter method, were used to found the colony in Colorado using mice from Rehovot. Transgenic heterozygote mice were bred using known homozygote and control parents, and heterozygote and control offspring were characterized using red blood cell superoxide dismutase assays (see below). Alternatively, mice expressing the human CuZnSOD gene were identified by polyacrylamide gel analysis of CuZnSOD activity (see below; references [15] [16] [17] . Additional CBYB6 X B6D2 control mice were bred from the parent strains (Bantin and Kingman, San Francisco, CA). Thereafter, additional experimental animals were obtained by breeding homozygote, heterozygote, or control males with control females, and offspring were identified with red blood cell SOD assays and SOD activity gel electrophoresis.
Red blood cell superoxide dismutase activity assay. Mice were anesthetized by inhalation of metophane, and blood was removed with capillary tubes from the retroorbital plexus. Whole blood was diluted and red cells lysed in 50 mM potassium phosphate buffer (pH 7.8) containing 0.1% NP40. After overnight dialysis to remove low molecular weight substances which reduce ferricytochrome c, total SOD activity (pH 7.8) was measured (18) .
SOD activity gel electrophoresis. Tissue homogenates (-10-20 Mg tissue) or red blood cell hemolysates (1:20, vol:vol in 50 mM potassium phosphate, pH 7.8; 20 ul) were loaded onto a 10% acrylamide gel and electrophoresed for -3 h at 150 V. Staining for SOD enzymatic activity was done as described elsewhere (17) except that the gels were soaked in nitroblue tetrazolium for 20 min, followed by additional soaking for 15 min in tetramethylethylenediamine/riboflavin in potassium phosphate buffer. Distinct bands representing mouse SOD, mouse-human SOD heterodimer, human SOD, and hemoglobin were identified on these gels.
Exposure to hyperoxia. Mice were housed in plexiglas chambers flushed continuously with oxygen from a liquid source (10 liter/min) and maintained at Denver atmospheric pressure (630 torr) or at sea level atmospheric pressure (760 torr) by regulation ofchamber outflow with a water manometer. This provided sufficient flow to maintain measured oxygen concentration consistently > 99% and CO2 concentration < 0.5%. Relative humidity was 50-70o. Lighting was on a 12-h on/off cycle. Food and water were provided ad libitum. Mice were observed every 12 h for evidence of respiratory distress and survival.
Unless males were housed individually, fighting stress contributed significantly to the mortality ofmale mice in both normoxic and hyperoxic environments. Therefore, limited numbers of exposures of males to hyperoxia were done. Female mice were used for all subsequent studies of lung morphology and biochemistry.
Lung morphology studies. After exposure to hyperoxia for 168 h, or less in those mice that expired or showed severe respiratory distress, mice were euthanized with pentobarbital (120 mg/kg i.p.) and tracheostomy and placement of a tracheal cannula were rapidly performed. Lungs were fixed by intratracheal infusion ofbuffered glutaraldehyde (2.5%; 100 mM potassium phosphate, pH 7.4) in situ at 15 cm H20 pressure. After 30 min, lungs were dissected free, immersed in fixative, and coded for further processing and analysis. Histologic damage, as indicated by accumulation of edema fluid, hyaline membrane formation, and septal thickening, was qualitatively determined by a pathologist (P. F. Shanley), using the coded specimens. Each sample was assessed specifically both for the presence or absence of significant pulmonary edema and of hyaline membranes. Lung neutrophils were counted on hematoxylin-eosin stained sections (5-Mm sections).
Lung biochemical studies. After lethal injection of pentobarbital, lungs of mice were perfused via the pulmonary artery with PBS (pH 7.4, 5 mM potassium phosphate). Right lungs were homogenized for 30 s (4°C) in 50 mM potassium phosphate, pH 7.8, using a Virtishear (Virtis, Gardiner, NY). Lungs were centrifuged for 10 min (15,000 g).
The supernatant was retained for enzyme activity measurements, and the pellet for insoluble protein determination (19) . Activities ofcatalase (20), glutathione peroxidase (21) and reductase (21) , and glucose-6phosphate dehydrogenase (21) were determined spectrophotometrically. Lung antioxidant enzyme activities were corrected for activity due to blood contamination using the dithionite-sensitive reduction of hemoglobin (22) . After overnight dialysis of an aliquot of the lung homogenate, SOD activity was measured spectrophotometrically (18) . In aliquots studied without dialysis, total SOD, CuZnSOD, and MnSOD activities also were determined based on the differential activity of CuZnSOD in the presence and absence of increased concentrations of cyanide (5 mM). This more sensitive assay system contained diethylenetriaminepentaacetic acid (1 mM), bathocuproinedisulfonic acid (0.06 mM), and bovine liver catalase (1.25 U/ml) in addition to xanthine, xanthine oxidase, and nitroblue tetrazolium (23) . DNA was determined using the left lung (24) .
Statistical analyses. For each sex/age/pressure combination, the survival function of each group (control, transgenic) was estimated using the Kaplan-Meier method, and then the two distributions were compared using a Wilcoxon test (Gehan's test, 25) . Mean (±SEM) survival times are reported for studies in which all members ofboth groups had died by the end of the study.
Data from histopathologic studies were compared using the Pearson Chi-square analysis. Lung antioxidant enzyme activity data were analyzed using a two-way factorial analysis of variance to examine for group-and time-related main effects and a group-by-time interaction. If the interaction was found to be significant, independent sample Student's t tests were done for group differences at each level of time. Likewise, time differences within each group were examined with t tests or one-way ANOVA as appropriate. Ifthe interaction was not found to be significant, main effects from the two-way ANOVA were examined. Time effects were evaluated using a linear contrast in the means, after the ANOVA, using defined a priori contrasts (26). A P value < 0.05 was taken as the level of significance for all analyses.
Results
Survival. The survival ofyoung (2.5 mo age), female transgenic heterozygote mice (11/11, 100%) was greater than that observed in age-matched controls (11/33, 33%) during exposure to hyperoxia at Denver atmospheric pressure (630 torr) for 10 d (P = 0.0009; Fig. 1 A) . Young male transgenic heterozygotes also had marginally significantly increased survival (5/6, 83%) when compared to age-matched controls (3/8, 38%; P = 0.054). In older (5.5 mo age) female mice, survival oftransgenic heterozygote mice decreased to 50% (8/16), whereas survival of controls was 27% (7/26; Fig. 1 . The difference in survival distributions was marginally significant in females (P = 0.068) and significant in males (P = 0.013).
Histopathology. After oxygen exposure (630 torr) for 168 h, pulmonary edema formation (56% ofcontrols vs. 13% oftransgenics, P = 0.013, Pearson chi-square analysis) and hyaline membranes (50% ofcontrols vs. 13% oftransgenics, P = 0.029, Pearson chi-square analysis) were greater in control than transgenic mice. The lungs of the majority (9/16) of these young female control mice had histopathologic evidence of severe confluent pulmonary edema and diffuse hyaline membrane formation as well as marked septal thickening, vascular conges- tion, and diffuse inflammation ( Fig. 2 A) . Eight of these nine animals died within < 168 h. The lungs of the remaining animals (7/16) showed less severe pulmonary inflammation and vascular congestion. A minority (2/15) of young heterozygous transgenic mice had severe pulmonary edema and hyaline membrane formation comparable with that seen in the majority of controls. Only one of these two animals died during the 168-h exposure period. The lungs of the remainder (13/15) of the transgenic mice had less severe inflammation and vascular congestion comparable with that seen in the minority of controls (Fig. 2 B) .
In older control female mice exposed to hyperoxia for 156 h, marked pulmonary edema and/or hyaline membrane formation occurred in the lungs of 2/7 animals, whereas it was present in none (Q/7) of the transgenic heterozygotes. There were no other histopathologic differences which could be distinguished between the two groups at this time, and no deaths had occurred in either group. Nonetheless, the numbers of neutrophils present in lungs ofolder transgenic heterozygote (17±4/5 high-power fields, n = 7) mice were fewer than those counted in lungs of control (90±29/5 high-power fields, n = 7; P < 0.05) mice. A similar trend occurred in the lungs ofyoung transgenic (41±5/5 high-power fields) compared with control (79±26/5 high-power fields, n = 7; P = 0.07) mice after their exposure to hyperoxia for 168 h. However, these analyses excluded all lungs from mice with gross pulmonary edema and hyaline membrane formation because substantial volume loss had occurred in those lungs.
Enzymatic differences in normoxia. Red cell SOD activity was increased in heterozygote transgenic mice compared with control mice from the same parent strain (SOD activity, 45,402±2,077 U/g hemoglobin, n = 9, for heterozygotes; vs. 13,996±341 U/g hemoglobin, n = 15, for controls; P < 0.0001). Although the differences in redblood cell SOD activity were great enough that transgenic heterozygote mice readily could be distinguished from control mice on the basis of these results, we confirmed the accuracy of this means of identification using electrophoretic identification of mouse and human CuZnSOD activity bands (16, 17) in samples ofred blood cells and homogenates of lungs, kidneys, and other tissues from these mice.
Likewise, the total activity of SOD in lung tissue from young (2.5 mo old) transgenic heterozygous animals was found to be 310±25 U/mg DNA (n = 14) compared to 146±8 U/mg DNA (n = 20; P < 0.0001) in controls using the ferricytochrome c assay system. Using the more sensitive nitroblue tetrazolium assay system, CuZnSOD activity was increased similarly in lungs from young transgenic heterozygous animals (1,330±117 U/mg DNA; n = 6) compared with controls (527±37 U/mg DNA, n = 7; P < 0.0001). However, absolute MnSOD activity was not different in lungs from these transgenic heterozygous mice (38±9 U/mg DNA, n = 6) relative to controls (44±8 U/mg DNA, n = 7; P = 0.60). The increase in CuZnSOD activities in the lungs from transgenic compared with control mice also was apparent in the SOD activity gels upon which CuZnSOD and MnSOD migrate differently. Older transgenic heterozygote mice had similar, if not greater, absolute and relative increases in lung total SOD activity relative to controls as compared with their younger counterparts ( Fig. 3 
, A; time 0 h columns).
In addition, lung glucose-6-phosphate dehydrogenase (G6PD; 0.240±0.014 U/mg DNA, n = 29; vs. 0.156±0.011 U/mg DNA, n = 33, for controls; P < 0.001) and glutathione peroxidase (GPX; 1.67±0.09, n = 29; vs. 1.26±0.04, n = 33, for controls; P < 0.001) activities were greater in young (2.5 mo old) transgenic heterozygote compared with control mice during exposure to normoxia. Lung glutathione reductase, but not catalase, activities also tended to be higher in transgenic than control mice, but these differences were not significant. Constitutive overexpression ofG6PD and GPX did not occur in older (5.5 mo old) transgenic mice relative to controls (Fig. 3 
, B-E; time 0 h columns).
Enzymatic differences in hyperoxia. Among transgenic heterozygote and control mice successfully adapting to hyperoxia, lung G6PD and GPX activities increased two-to threefold relative to baseline (normoxia) in young mice ofboth groups after 10 d (Fig. 3, B and C, time 240 h columns). At that time, lung glutathione reductase activity also increased by -50% in both young transgenic and surviving control mice during oxygen adaptation ( Fig. 3 D, time 240 h) . The rates of increase in lung activities of G6PD, GPX, and GR were not greater in young transgenic mice than controls (Fig. 3, B -D, time 120 h columns). Smaller increases in lung catalase activity occurred also in control and transgenic mice after adaptation (Fig. 3, E , time 240 h columns). However, total lung SOD activity did not increase in spontaneously adapting controls, and it tended to decline somewhat in the transgenic mice during adaptation. However, these decreases were not statistically significant Comparable changes were present in 13/15 oxygenexposed heterozygotes. (Both are hematoxylin-eosin stained; magnification, 50; both lungs inflated at 15 cm water pressure). (Fig. 3, A) . Lung G6PD, GPX, and GR activities increased significantly (P < 0.05) in older transgenic, but not control, mice after 240 h of 02 exposure. Changes in lung SOD and catalase activities occurring in older mice of either group during oxygen exposure were not significant (Fig. 3, A-E ).
Discussion
Expression of elevated levels of transgenic human CuZnSOD in mouse lung markedly prolonged survival of young mice in continuous normobaric hyperoxia at Denver (> 99% 02, 630 torr), but much less significantly at sea level atmospheric pressures (> 99% 02, 760 torr). Enhancement ofsurvival was signif-icant in young (2.5 mo old), but not older (5.5 mo old), mice. Associated decreases in histopathologic evidence of acute lung injury were present in transgenic compared with control mice. These findings indicate that expression of elevated levels of CuZnSOD has a measurable, although limited, capacity to decrease mammalian pulmonary oxygen toxicity.
Further investigation of the lung enzymatic response of young mice to hyperoxic injury showed that adaptation of transgenic heterozygote mice to hyperoxia is associated with increases in lung glucose-6-phosphate dehydrogenase, glutathione reductase, and peroxidase activities. Similar increases in lung activities of G6PD, GR, and GPX also occurred in the small percentage (33%) of spontaneously adapting control Transgenic Superoxide Dismutase Expression Protects Lungfrom°2 Toxicity 2165 mice. Considerably smaller increases in lung catalase activity occurred during adaptation of young control and transgenic mice. Interestingly, total lung SOD activity did not increase in the spontaneously adapting control mice, and it tended to decline somewhat in the transgenics during adaptation. Thus, it appears that an endogenous, age-related adaptive process not involving lung SOD, but possibly involving the glutathione redox system, is superimposed on the oxygen tolerance in mice conferred by increased lung SOD activity. In addition to this effect in young mice, the constitutive overexpression of G6PD and GPX may contribute to the improved survival of young compared with older transgenic mice. It is unclear why constitutively increased levels ofGPX and G6PD occur in normoxia only in the younger transgenic mice. However, constitutive overexpression of glutathione peroxidase has been observed recently in fibroblasts with increased expression of CuZnSOD (27) . In our studies, increases in the glutathione redox cycle enzymes during exposure to hyperoxia were associated with the adaptation process. However, at the latest time point before which deaths began to occur in the control group (120 h), we did not find these increases to be occurring more rapidly or to a greater extent in transgenic compared with control mice. Because ofattrition, it is not possible to know ifsevere lung injury in control mice of both ages or of older transgenic mice was associated with failure to induce glutathione redox cycle enzymes. This effect had not yet begun to occur by 120 h of exposure. After this time, mortality began to occur in each of these groups. Therefore, additional factors may be involved in the different levels of protection observed in the 2.5-and 5.5mo-old transgenic mice. Young mice and animals from multiple other species are much more likely than older animals to develop tolerance to lethal hyperoxic lung injury (9) . Our findings strongly suggest that factors other than increased lung SOD activity alone may be required to explain these differences. Nonetheless, the combination of (a) constitutively increased lung SOD activity, (b) constitutively increased activities oflung glutathione redox cycle enzymes (G6PD and GPX), and (c) additional increases in activities of lung glutathione redox cycle enzymes in response to hyperoxia (G6PD, GPX, and GR) occurred only in young transgenic mice, and only they showed prolonged tolerance to hyperoxia. Protection afforded by the first two factors, then, may have allowed the third effect to be manifested more completely in the young transgenic mice. However, we speculate that the age-dependent findings demonstrated here also could be a reflection ofmore rapid and efficient healing and repair mechanisms in the younger animals. The evidence provided by these studies is more direct than many preceding mammalian studies in that SOD expression is the primary variable being manipulated. Additional sublethal stresses such as preexposure to hyperoxia, hypoxia, or endotoxin are not imposed, and alterations in membrane lipids or phagocyte functions, as may occur in liposome-bound enzyme augmentation, do not occur.
The mechanisms whereby protection against pulmonary oxygen toxicity by expression of elevated levels of transgenic superoxide dismutase occurs are not entirely clear. Certainly, abundant experimental data demonstrate that excessive quantities of toxic oxygen metabolites, including superoxide and hydrogen peroxide, are formed at multiple cellular sites during exposure of lungs or other organs to hyperoxic environments (28) . Increased levels of CuZnSOD could decrease toxicity by decreasing superoxide available for damaging direct or indirect reactions with cellular constituents. In addition, it is possible that increased levels of SOD acted to decrease harmful secondary reactions ofsuperoxide such as the formation ofproinflammatory chemotaxins (29) . Indeed, neutrophil chemotaxins and related inflammation may contribute to hyperoxia-related lung damage and death in mice exposed to oxygen for the relatively prolonged durations and under the same pressures as those used in this study (30) . Nonetheless, the finding ofsmaller numbers of neutrophils in lungs from protected transgenic relative to control mice does not indicate if indeed these decreases occurred due to decreased concentrations of superoxide-dependent neutrophil chemotaxins or simply on the basis of decreased lung injury in the former.
Because production oftoxic 02 products increases with oxygen tension (28) , SOD and the glutathione redox system, even at increased levels of expression, probably were less capable of metabolizing these at the increased levels produced at the higher 02 tension studied (760 torr, sea level atmospheric pressure). This probably explains the poorer survival of animals exposed at 760 torr. Even at these higher pressures, there is no evidence from our studies that this level of increased lung CuZnSOD activity causes any enhanced toxicity or tissue injury in a hyperoxic environment.
Previously, we have evaluated three different in vivo models for tolerance to hyperoxic lung damage induced environmentally or pharmacologically in rats (preexposure to hypoxia, the cytokines IL-I plus tumor necrosis factor, or to polyethylene glycol (PEG)-attached antioxidant enzymes [12, 13, 31, 32] ). Protection, evidenced by decreased lung damage and mortality, was accompanied in each model by exogenously or endogenously increased superoxide dismutase. In tolerance induced by exogenously administered PEG-attached SOD and catalase, in which circulating, but not lung tissue, superoxide dismutase activity was increased appreciably by this treatment, protection was less impressive than in tolerance induced by hypoxia or cytokines, in which endogenous lung SOD activity did increase. Because lung-associated SOD activity was increased with the current intervention, this may explain the successful production of lung 02 tolerance in a species in which this does not normally occur outside the neonatal period (9) .
In each model in which we evaluated lung antioxidant enzyme activities in oxygen-adapted animals, we found also that increases in activities of enzymes of the hexose monophosphate shunt and glutathione redox cycle occurred concomitantly with adaptive increases in superoxide dismutase activity. enzyme (G6PD, GPX, and GR) activities occurred in young and older transgenic mice, and in the surviving 33% of young (2.5 mo old) control mice. However, these increases occurred only after 240 h. Although significant during both intervals in young controls, the additional increase in GPX activity in young transgenic mice between times 0 and 240 h was not significant, whereas it was marginally significant (P = 0.06) between 120 and 240 h. These enzymes did not increase in older control mice, except in the case of G6PD where a marginally significant (P = 0.06) activity increase occurred after 240 h. Lung CAT activity increased significantly (P < 0.05) in young control and transgenic mice after 240 h compared with time 0 or 120 h. Lung CAT did not change significantly in older mice. Thus, multiple systems, including the one described here, point to a strong interdependence between glutathione-dependent systems and superoxide dismutase in the evolution of endogenous tolerance to hyperoxic pulmonary injury.
Our results show a successful adaptation to hyperoxia in transgenic mice with constitutive expression of elevated levels of CuZnSOD. Therefore, therapeutic strategies involving induction of the host's own intracellular SOD(s) could be useful in preventing potential ill effects of treatment for the respiratory distress syndromes of both infants and adults. Furthermore, our findings with the CuZnSOD-transgenic mice suggest that, indeed, excessive superoxide, or one of its toxic products such as HO2. or HO-, causes or contributes to pulmonary oxygen toxicity.
